Support The Moscow Times!

Takeda Gets License

Japanese pharmaceuticals company Takeda secured a production license for its factory in Yaroslavl, the company announced last week, Interfax reported. Construction was completed in September 2012.

The factory can produce drugs in solid and liquid form, including sterile solutions for injection, pills with various coatings and uncoated pills.

Under the license, the factory can manufacture both Takeda's own drugs and those of other companies with which it has contracts. The factory is expected to initially produce 90 million sterile ampoules and vials and more than 2 billion pills per year.

Takeda plans to begin packaging injection drugs this summer and begin full production at the start of 2014. The company invested 75 million euros ($98 million) in the facility, which is in the Yaroslavl pharmaceuticals cluster.


Read more

Independent journalism isn’t dead. You can help keep it alive.

As the only remaining independent, English-language news source reporting from Russia, The Moscow Times plays a critical role in connecting Russia to the world.

Editorial decisions are made entirely by journalists in our newsroom, who adhere to the highest ethical standards. We fearlessly cover issues that are often considered off-limits or taboo in Russia, from domestic violence and LGBT issues to the climate crisis and a secretive nuclear blast that exposed unknowing doctors to radiation.

Please consider making a one-time donation — or better still a recurring donation — to The Moscow Times to help us continue producing vital, high-quality journalism about the world's largest country.